? LEADERSHIP, PLANNING AND EVALUATION Under the new UWCCC Director Howard Bailey, MD, a number of critical steps were taken in the planning and evaluation process during the current grant period include the following: assembled a revised EAB to evaluate the UWCCC; increased scientific forums for collaborative efforts in response to strategic priorities; obtained expert evaluations for strategic planning; and conducted off-site peer visits. Change of leadership in any organization provides an opportunity for assessment and redirection. In 2015, new UWCCC leadership priorities embraced an assessment of all internal operations, surveillance of the Oncology research environment, and the eventual application of analysis-driven redirection. This occurred through regular and strategic planning meetings of individual focus groups/committees of the Cancer Service Line; Executive Leadership Council; Senior Leadership Committee; Director?s Committee; Membership Committee; Ad-Hoc External Scientific Advisors; External Advisory Board; and annual scientific retreats. UWCCC added new leadership with the appointments of new Associate Director(s) in Faculty Development and Education, Clinical Research, Administration, Basic Sciences, Translational Research, and Shared Resources. Existing leadership from the prior renewal include Associate Directors in Population Sciences and in Informatics. All UWCCC leadership roles further the center?s mission by serving faculty members, serving employees, serving our patients, and serving our catchment area. We work collectively to guide planning and evaluations, create a vision, set goals, assess progress, and set the agenda for future directions. Senior Leadership determines strategies to leverage the breadth and depth of science on the UW-Madison campus. Meeting at least monthly, they carefully identify and foster research capabilities that will strengthen the UWCCC?s Scientific Programs and extend cancer focus into new areas.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014520-44
Application #
9490030
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-30
Budget End
2019-03-31
Support Year
44
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Ni, Dalong; Ferreira, Carolina A; Barnhart, Todd E et al. (2018) Magnetic Targeting of Nanotheranostics Enhances Cerenkov Radiation-Induced Photodynamic Therapy. J Am Chem Soc 140:14971-14979
Chang, Julie E; Carmichael, Lakeesha L; Kim, KyungMann et al. (2018) VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. Clin Lymphoma Myeloma Leuk 18:e61-e67
Guerrero, Natalie; Small, Alissa L; Schwei, Rebecca J et al. (2018) Informing physician strategies to overcome language barriers in encounters with pediatric patients. Patient Educ Couns 101:653-658
Chapelin, Fanny; Capitini, Christian M; Ahrens, Eric T (2018) Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer. J Immunother Cancer 6:105
DuBenske, Lori L; Schrager, Sarina B; Hitchcock, Mary E et al. (2018) Key Elements of Mammography Shared Decision-Making: a Scoping Review of the Literature. J Gen Intern Med 33:1805-1814
Wang, Dongdong; Shi, Ruohong; Zhou, Jiajia et al. (2018) Photo-Enhanced Singlet Oxygen Generation of Prussian Blue-Based Nanocatalyst for Augmented Photodynamic Therapy. iScience 9:14-26
Pearson, Hannah E; Iida, Mari; Orbuch, Rachel A et al. (2018) Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol. Mol Cancer Ther 17:204-214
Mora-Pinzon, Maria C; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2018) Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk. Nutr Cancer 70:441-446
Zahm, Christopher D; Colluru, Viswa T; McIlwain, Sean J et al. (2018) TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells. Cancer Immunol Res 6:1364-1374
Chen, Feng; Goel, Shreya; Shi, Sixiang et al. (2018) General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting. Nano Res 11:4890-4904

Showing the most recent 10 out of 1528 publications